Cancer is clever and when it becomes a health event, the tumour(s) emit enzymes that put a ‘blindfold’ on the immune system. This means that the dendritic cells that we naturally produce never recognise the cancer as an ‘enemy’.
With lab matured dendritic cells we interrupt this process and prime the dendritic cells with the antigen of the patient’s particular cancer. Many clinical papers confirm the safety and the efficacy of this treatment either alone or in combination with other treatments. The Nobel medicine prize was awarded for this discovery and protocol.